Literature DB >> 24507844

Smoking cessation.

Stephen I Rennard1, David M Daughton2.   

Abstract

Cigarette smoking is a major preventable cause of morbidity and mortality. It is the major risk factor for chronic obstructive pulmonary disease in the developed world. Smoking is a chronic relapsing disease. Optimal treatment includes nonpharmacologic support, together with pharmacotherapy. All clinicians should be comfortable with the use of nicotine replacement therapy, bupropion, and varenicline. Second-line therapies can be used by those familiar with their use. Effective use of these medications requires their integration into an effective management plan, which is likely to be a long-term undertaking, involving several cycles of remission and relapse.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cessation; Pharmacotherapy; Smoking; Treatment

Mesh:

Substances:

Year:  2014        PMID: 24507844     DOI: 10.1016/j.ccm.2013.11.002

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  7 in total

1.  Effect of network social capital on the chances of smoking relapse: a two-year follow-up study of urban-dwelling adults.

Authors:  Spencer Moore; Ana Teixeira; Steven Stewart
Journal:  Am J Public Health       Date:  2014-10-16       Impact factor: 9.308

Review 2.  Nicotine withdrawal.

Authors:  Ian McLaughlin; John A Dani; Mariella De Biasi
Journal:  Curr Top Behav Neurosci       Date:  2015

Review 3.  Non-pharmacological management of chronic obstructive pulmonary disease.

Authors:  Katherine A Safka; R Andrew McIvor
Journal:  Ulster Med J       Date:  2015-01

4.  Association of occupational dust exposure with combined chronic obstructive pulmonary disease and pneumoconiosis: a cross-sectional study in China.

Authors:  Yali Fan; Wenjing Xu; Yuanying Wang; Yiran Wang; Shiwen Yu; Qiao Ye
Journal:  BMJ Open       Date:  2020-09-09       Impact factor: 2.692

5.  Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.

Authors:  Carlos A Jiménez-Ruiz; Segismundo Solano-Reina; Jaime Signes-Costa; Eva de Higes-Martinez; José I Granda-Orive; José J Lorza-Blasco; Juan A Riesco-Miranda; Neus Altet-Gomez; Miguel Barrueco; Itziar Oyagüez; Javier Rejas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-24

Review 6.  Integrated Palliative Care and Oncologic Care in Non-Small-Cell Lung Cancer.

Authors:  Divya Chandrasekar; Erika Tribett; Kavitha Ramchandran
Journal:  Curr Treat Options Oncol       Date:  2016-05

7.  Regional heterogeneity in response of airway epithelial cells to cigarette smoke.

Authors:  Hario Baskoro; Tadashi Sato; Keiko Karasutani; Yohei Suzuki; Aki Mitsui; Naoko Arano; Fariz Nurwidya; Motoyasu Kato; Fumiyuki Takahashi; Yuzo Kodama; Kuniaki Seyama; Kazuhisa Takahashi
Journal:  BMC Pulm Med       Date:  2018-09-04       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.